Industry: Healthcare Region: South Korea Transaction Price: USD 1 million Transaction Method: Equity investment
Introduction to the Project:
A family-owned business founded in 1968 that primarily "cures" patients, it offers a wide range of products including drugs, medical devices, in vitro diagnostic tests, pharmacogenetic assays, and food supplements.
Major areas: Cardiovascular, rheumatology, Nephrology/urology, and central system.
Secondary field: Oncology/radiotherapy.
The company has built strong relationships with doctors and the scientific community, allowing it to launch new products on the market and even develop new markets for established products. The company's sales team covers all of Spain.
It has been developing its export business since 1982. The international business now accounts for one-third of the company's total turnover and invests in expansion projects in existing and new markets, with a special focus on emerging market countries. We operate in more than 50 countries through our partners.
Specifically looking for does not exist or is not in Spain to promote a new type of medical device or prescription drugs, we can through our experienced activities in business promotion, including the medical apparatus and instruments, prescription drugs or other require a doctor's prescription or recommend products, applicable to the cardiovascular, rheumatis m, kidney disease, male urology/and central nervous system, As well as patient solutions in therapeutic areas such as oncology/radiotherapy, or specialists seeking partners for R&D or technical expertise that can develop the kind of product we are looking for and either lack their own commercial solutions in Spain or are looking for better solutions.